Casdin Capital’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,154,476
| Closed | -$12.1M | – | 55 |
|
|
2021
Q2 | $12.1M | Sell |
1,154,476
-86,700
| -7% | -$909K | 0.31% | 41 |
|
|
2021
Q1 | $14.6M | Hold |
1,241,176
| – | – | 0.44% | 37 |
|
|
2020
Q4 | $14.5M | Sell |
1,241,176
-200,000
| -14% | -$2.34M | 0.43% | 39 |
|
|
2020
Q3 | $11.4M | Hold |
1,441,176
| – | – | 0.51% | 34 |
|
|
2020
Q2 | $26.4M | Buy |
1,441,176
+231,891
| +19% | +$4.24M | 1.56% | 22 |
|
|
2020
Q1 | $14.4M | Sell |
1,209,285
-30,000
| -2% | -$358K | 1.53% | 20 |
|
|
2019
Q4 | $20.6M | Buy |
1,239,285
+395,000
| +47% | +$6.57M | 1.9% | 17 |
|
|
2019
Q3 | $5.61M | Buy |
+844,285
| New | +$5.61M | 0.58% | 29 |
|